| 
				健保碼及健保價 | 
		 
		
			| 
				See related Orfadin cap information | 
		 
		
			| 
				  | 
		 
		
			| 
				製造商 | 
			
				Swedish | 
		 
		
			| 
				代理/經銷商 | 
			
				TSPC | 
		 
		
			| 
				成份 | 
			
				Nitisinone | 
		 
		
			| 
				適應症 | 
			
				Adjunct to dietary restriction of tyrosine & phenylalanine in the treatment of hereditary tyrosinemia type 1. | 
		 
		
			| 
				用量 | 
			
				Initially, 1 mg/kg/day in divided doses (morning & evening). If necessary, the dose may be increased after 1 month to 1.5 mg/kg/day; max daily dose: 2 mg/kg. | 
		 
		
			| 
				注意事項 | 
			
				Monitor platelet & white blood cell counts during therapy; plasma tyrosine levels should be kept below 500 micromole/L in order to avoid toxic effects to the eyes, skin & nervous system; advise patient to consult a doctor immediately if they develop visual disturbances during treatment; regular liver monitoring by imaging & lab tests, including serum α-fetoprotein conc is recommended. | 
		 
		
			| 
				不良反應 | 
			
				Alopecia, dry skin, exfoliative dermatitis, maculopapular rash, pruritis; leukopenia, thrombocytopenia, epistaxis, porphyria; conjunctivitis, corneal opacity, keratitis, photophobia; blepharitis, cataracts, eye pain; hepatic neoplasm, liver failure. 
				View ADR Monitoring Website[參閱藥物不良反應監測表格] | 
		 
	
 
 
	
		
			| 
				本商品之市售規格 | 
		 
		
			| 
				
				 | 
		 
		
			
				
					
						
							
								
									
										
											| 
												Manufacturer: | 
											
												Swedish | 
										 
										
											| 
												Distributor: | 
											
												TSPC | 
										 
									
								 
							 | 
							
								  | 
							
								 
								 
								  | 
						 
					
				 
			 | 
		 
	
 
 |